NIVF — NewGenIvf Cashflow Statement
0.000.00%
Last trade - 00:00- $0.58m
- $3.53m
- $4.73m
Annual cashflow statement for NewGenIvf, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 20-F | 20-F | 20-F |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.139 | 0.136 | 0.108 | -0.474 | 9.73 |
| Depreciation | |||||
| Non-Cash Items | 0.383 | 0.568 | 0.185 | -0.052 | -19.2 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 1.02 | 0.906 | -2.09 | -7.76 | -1.61 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 1.43 | 1.71 | -1.77 | -8.26 | -10.9 |
| Capital Expenditures | -0.017 | -0.094 | -0.07 | -0.053 | -0.135 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | — | — | — | -7.42 |
| Acquisition of Business | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.017 | -0.094 | -0.07 | -0.053 | -7.56 |
| Financing Cash Flow Items | -2.04 | -1.74 | 1.7 | -0.029 | -0.174 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -1.54 | -1.63 | 1.88 | 8.68 | 19 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.077 | -0.001 | 0.027 | 0.404 | 0.301 |